✦ LIBER ✦

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

✍ Scribed by Alfred von Krempelhuber; Jens Vollmar; Rolf Pokorny; Petra Rapp; Niels Wulff; Barbara Petzold; Amanda Handley; Lyn Mateo; Henriette Siersbol; Herwig Kollaritsch; Paul Chaplin

Book ID: 116962255
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 494 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.11.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, phase II dose-finding studie

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

✍ Hartmut J. Ehrlich; Borislava G. Pavlova; Sandor Fritsch; Eva-Maria Poellabauer; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase I/II randomized, double-blind, p

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

✍ AK Gupta; C Leonardi; RR Stoltz; PF Pierce; B Conetta; the Ravuconazole onychomy 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

S1419: A Phase IIa, Randomized, Controll

S1419: A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy

✍ Dennis S. Riff; Peter J. Winkle; Howard I. Schwartz; James Lees; Karin Wilhelm-O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Randomized double-blind placebo-controll

Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

✍ E. H. J. Weil; P. H. A. Eerdmans; G. A. Dijkman; K. Tamussino; J. Feyereisl; M. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 756 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB